Chronic urticaria and COVID-19 vaccination: Qatar data (preliminary report of COVAC-CU-international)

Background: It is a well-known fact that patients with chronic urticaria (CU) are not at a higher risk for a serious allergic reaction such as anaphylaxis from medications. However, there is a fear and some misconceptions regarding allergic reactions to the COVID-19 vaccine among patients and physic...

Descripción completa

Detalles Bibliográficos
Autores principales: Purayil, Saleema, Thalappil, Sherin, Al-Nesf, Maryam, Kocaturk, Emek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: HBKU Press 2022
Materias:
First Qatar Allergy Conference
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340567/
https://www.ncbi.nlm.nih.gov/pubmed/35968517
http://dx.doi.org/10.5339/qmj.2022.fqac.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340567/
https://www.ncbi.nlm.nih.gov/pubmed/35968517
http://dx.doi.org/10.5339/qmj.2022.fqac.2

Ejemplares similares